NICE recommends Celgene ’s pancreatic cancer treatment abraxane for NHS use

The UK National Institute for Health and Care Excellence (NICE) has recommended the routine use of Celgene ’s nab-paclitaxel as a life-extending treatment for patients with progressive pancreatic cancer that has progressed.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news